Stammdaten
Unternehmen
| Name | Adaptive Biotechnologies Corp |
|---|---|
| Ticker | ADPT |
| CIK | 0001478320 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Adaptive Biotechnologies Corp |
Status
| Zuletzt geprüft | 2026-03-20 22:35:42.109149 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 276,976,000 | -59,499,000 | -0.39 | 512,736,000 | 218,793,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 13.83 | -263,599.80 | -31,2% | |
| 2026-03-20 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 13.37 | -254,832.20 | -30,1% | |
| 2026-03-19 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 13.18 | -251,210.80 | -29,7% | |
| 2026-03-18 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 13.18 | -251,210.80 | -29,7% | |
| 2026-03-17 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 13.40 | -255,404.00 | -30,2% | |
| 2026-03-16 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 13.41 | -255,594.60 | -30,2% | |
| 2026-03-13 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 12.96 | -247,017.60 | -29,2% | |
| 2026-03-13 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 12.96 | -247,017.60 | -29,2% | |
| 2026-03-12 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -13,660 | 12.63 | -172,525.80 | -20,4% | |
| 2026-03-12 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -5,400 | 13.43 | -72,522.00 | -8,6% | |
| 2026-03-12 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -13,660 | 12.63 | -172,525.80 | -20,4% | |
| 2026-03-12 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -5,400 | 13.43 | -72,522.00 | -8,6% | |
| 2026-03-11 | BOBULSKY SUSAN | Officer, Chief Commercial Officer, MRD | Open Market Sale | -41,338 | 13.17 | -544,421.46 | -64,4% | |
| 2026-03-11 | GRIFFIN MICHELLE RENEE | Director | Open Market Sale | -15,394 | 13.91 | -214,130.54 | -25,3% | |
| 2026-03-11 | GRIFFIN MICHELLE RENEE | Director | Open Market Sale | -15,394 | 13.91 | -214,130.54 | -25,3% | |
| 2026-03-11 | GRIFFIN MICHELLE RENEE | Director | Open Market Sale | -15,394 | 13.91 | -214,130.54 | -25,3% | |
| 2026-03-11 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 14.08 | -268,364.80 | -31,7% | |
| 2026-03-11 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -122,523 | 13.17 | -1,613,627.91 | -190,7% | |
| 2026-03-11 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,060 | 14.08 | -268,364.80 | -31,7% | |
| 2026-03-11 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -122,523 | 13.17 | -1,613,627.91 | -190,7% | |
| 2026-03-11 | BENZENO SHARON | Officer, Chief Commercial Ofc Imm Med | Open Market Sale | -63,103 | 13.17 | -831,066.51 | -98,2% | |
| 2026-03-11 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -30,593 | 14.08 | -430,749.44 | -50,9% | |
| 2026-03-11 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -329,600 | 13.17 | -4,340,832.00 | -513,1% | |
| 2026-03-11 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -140,567 | 13.17 | -1,851,267.39 | -218,8% | |
| 2026-03-11 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -140,666 | 13.17 | -1,852,571.22 | -219,0% | |
| 2026-03-11 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -329,600 | 13.17 | -4,340,832.00 | -513,1% | |
| 2026-03-11 | PISKEL KYLE | Officer, Chief Financial Officer | Open Market Sale | -18,672 | 13.17 | -245,910.24 | -29,1% | |
| 2026-03-10 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,460 | 14.68 | -285,672.80 | -33,8% | |
| 2026-03-10 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -19,460 | 14.68 | -285,672.80 | -33,8% | |
| 2026-03-09 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 14.79 | -457,617.39 | -54,1% | |
| 2026-03-09 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 14.79 | -457,617.39 | -54,1% | |
| 2026-03-06 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 15.14 | -468,446.74 | -55,4% | |
| 2026-03-06 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 15.14 | -468,446.74 | -55,4% | |
| 2026-03-05 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -38,074 | 15.09 | -574,536.66 | -67,9% | |
| 2026-03-05 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 16.00 | -495,056.00 | -58,5% | |
| 2026-03-05 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 16.00 | -495,056.00 | -58,5% | |
| 2026-03-04 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 16.60 | -513,620.60 | -60,7% | |
| 2026-03-04 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -30,941 | 16.60 | -513,620.60 | -60,7% | |
| 2026-03-03 | GRIFFIN MICHELLE RENEE | Director | Open Market Sale | -48,044 | 15.30 | -735,073.20 | -86,9% | |
| 2026-03-03 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -50,703 | 15.49 | -785,389.47 | -92,8% | |
| 2026-03-03 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -2,380 | 16.15 | -38,437.00 | -4,5% | |
| 2026-03-03 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -6,518 | 16.33 | -106,438.94 | -12,6% | |
| 2026-03-03 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -24,423 | 15.49 | -378,312.27 | -44,7% | |
| 2026-03-03 | GRIFFIN MICHELLE RENEE | Director | Open Market Sale | -48,044 | 15.30 | -735,073.20 | -86,9% | |
| 2026-03-03 | GRIFFIN MICHELLE RENEE | Director | Open Market Sale | -48,044 | 15.30 | -735,073.20 | -86,9% | |
| 2026-03-03 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -6,518 | 16.33 | -106,438.94 | -12,6% | |
| 2026-03-03 | RUBINSTEIN JULIE | Officer, President and COO | Open Market Sale | -24,423 | 15.49 | -378,312.27 | -44,7% | |
| 2026-03-03 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -14,233 | 16.52 | -235,129.16 | -27,8% | |
| 2026-03-02 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -10,000 | 15.72 | -157,200.00 | -18,6% | |
| 2026-03-02 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -289,024 | 15.82 | -4,572,359.68 | -540,5% | |
| 2026-02-27 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -182,891 | 15.99 | -2,924,427.09 | -345,7% | |
| 2026-02-04 | PISKEL KYLE | Officer, Chief Financial Officer | Open Market Sale | -2,145 | 18.46 | -39,596.70 | -4,7% | |
| 2026-02-03 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -8,120 | 19.00 | -154,280.00 | -18,2% | |
| 2026-02-02 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -124,998 | 18.44 | -2,304,963.12 | -272,5% | |
| 2026-02-02 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -34,668 | 18.60 | -644,824.80 | -76,2% | |
| 2026-01-12 | PISKEL KYLE | Officer, Chief Financial Officer | Open Market Sale | -4,290 | 18.00 | -77,220.00 | -9,1% | |
| 2026-01-12 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -79,590 | 17.73 | -1,411,130.70 | -166,8% | |
| 2026-01-06 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -10,000 | 16.44 | -164,400.00 | -19,4% | |
| 2026-01-05 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -124,998 | 15.59 | -1,948,718.82 | -230,4% | |
| 2026-01-02 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -3,125 | 16.08 | -50,250.00 | -5,9% | |
| 2025-12-22 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -4,394 | 17.50 | -76,895.00 | -9,1% | |
| 2025-12-22 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -4,394 | 17.50 | -76,895.00 | -9,1% | |
| 2025-12-15 | LO FRANCIS | Officer, Chief People Officer | Open Market Sale | -113,890 | 15.57 | -1,773,267.30 | -209,6% | |
| 2025-12-10 | HERSHBERG ROBERT | Director | Open Market Sale | -22,968 | 16.00 | -367,488.00 | -43,4% | |
| 2025-12-10 | HERSHBERG ROBERT | Director | Open Market Sale | -22,968 | 16.00 | -367,488.00 | -43,4% | |
| 2025-12-10 | HERSHBERG ROBERT | Director | Open Market Sale | -22,968 | 16.00 | -367,488.00 | -43,4% | |
| 2025-12-04 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -10,000 | 16.61 | -166,100.00 | -19,6% | |
| 2025-12-04 | BENZENO SHARON | Officer, Chief Commercial Ofc Imm Med | Open Market Sale | -12,604 | 16.85 | -212,377.40 | -25,1% | |
| 2025-12-03 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -27,212 | 18.61 | -506,415.32 | -59,9% | |
| 2025-12-01 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -124,998 | 18.94 | -2,367,462.12 | -279,9% | |
| 2025-11-28 | PISKEL KYLE | Officer, Chief Financial Officer | Open Market Sale | -162,820 | 19.50 | -3,174,990.00 | -375,3% | |
| 2025-11-26 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -35,736 | 19.68 | -703,284.48 | -83,1% | |
| 2025-11-21 | BENZENO SHARON | Officer, Chief Commercial Ofc Imm Med | Open Market Sale | -308,477 | 16.91 | -5,216,346.07 | -616,6% | |
| 2025-11-20 | BENZENO SHARON | Officer, Chief Commercial Ofc Imm Med | Open Market Sale | -297,925 | 16.54 | -4,927,679.50 | -582,5% | |
| 2025-11-17 | PISKEL KYLE | Officer, Chief Financial Officer | Open Market Sale | -238 | 14.05 | -3,343.90 | -0,4% | |
| 2025-11-12 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -1,867 | 15.00 | -28,005.00 | -3,3% | |
| 2025-11-11 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -1,237 | 14.57 | -18,023.09 | -2,1% | |
| 2025-11-10 | ROBINS HARLAN S | Officer, Chief Scientific Officer | Open Market Sale | -10,000 | 14.82 | -148,200.00 | -17,5% | |
| 2025-11-10 | ROBINS CHAD M | Director, Officer, CEO and Chairman | Open Market Sale | -86,161 | 14.73 | -1,269,151.53 | -150,0% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.